Malignant Ovarian Epithelial Tumor — Trials

Malignant Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

897 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 351–366 of 366 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00096395	Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer	completed	Phase 2	33	National Cancer Institute (NCI)NIH	1	Jun 13, 2013	clinicaltrials
NCT00026091	Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer	completed	Phase 2	40	National Cancer Institute (NCI)NIH	1	Mar 25, 2013	clinicaltrials